23444 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 15
00:24 UTC
|
ESTC
Elastic
|
◎ Target | Matthew Hedberg ★★★★☆ #756 | Outperform | $70.00→ $87.00+24.3% |
|
Aug 15
00:24 UTC
|
ESS
Essex Property Trust
|
◎ Target | Anthony Paolone ★★★☆☆ #1657 | Underweight | $275.00→ $295.00+7.3% |
|
Aug 15
00:24 UTC
|
ESNT
Essentra
|
◎ Target | firm only | Buy | GBX 160→ GBX 140-12.5% |
|
Aug 15
00:24 UTC
|
ERAS
Erasca
|
◎ Target | Alec Stranahan ★★★☆☆ #980 | Neutral | $18.00→ $20.00+11.1% |
|
Aug 15
00:24 UTC
|
EQB
EQB
|
◎ Target | firm only | Buy | C$123.00→ C$154.00+25.2% |
|
Aug 15
00:24 UTC
|
EOSE
Eos Energy Enterprises
|
◎ Target | Ryan Pfingst ★★☆☆☆ #2654 | Neutral | $8.00→ $5.00-37.5% |
|
Aug 15
00:24 UTC
|
ENVX
Enovix
|
◎ Target | George Gianarikas ★☆☆☆☆ #3012 | Buy | $15.00→ $10.00-33.3% |
|
Aug 15
00:24 UTC
|
EMR
Emerson Electric
|
◎ Target | Varun Govindaraj not yet tracked | Outperform | $169.00→ $186.00+10.1% |
|
Aug 15
00:24 UTC
|
EMBJ
Embraer-Empresa Brasileira de Aeronautica
|
◎ Target | Marcelo Motta not yet tracked | Overweight | $80.00→ $104.00+30.0% |
|
Aug 15
00:24 UTC
|
EIKN
Eikon Therapeutics
|
◎ Target | Robert Driscoll ★★★★★ #223 | Underperform | $5.00→ $4.00-20.0% |
|
Aug 15
00:24 UTC
|
EC
Ecopetrol
|
◎ Target | Tasso Vasconcellos not yet tracked | Neutral | $14.00→ $16.00+14.3% |
|
Aug 15
00:24 UTC
|
EAT
Brinker International
|
◎ Target | Katherine Griffin not yet tracked | Buy | $224.00→ $310.00+38.4% |
|
Aug 15
00:24 UTC
|
DT
Dynatrace
|
◎ Target | Miller Jump ★★★★★ #110 | Buy | $55.00→ $60.00+9.1% |
|
Aug 15
00:24 UTC
|
DIV
Diversified Royalty
|
◎ Target | firm only | Outperform | C$7.25→ C$7.00-3.4% |
|
Aug 15
00:24 UTC
|
DIV
Diversified Royalty
|
◎ Target | firm only | Buy | C$5.00→ C$4.75-5.0% |
|
Aug 15
00:24 UTC
|
DELL
Dell Technologies
|
◎ Target | Aaron Rakers ★★★★☆ #677 | Overweight | $505.00→ $545.00+7.9% |
|
Aug 15
00:24 UTC
|
DE
Deere & Company
|
◎ Target | Tami Zakaria ★★★☆☆ #1438 | Neutral | $590.00→ $570.00-3.4% |
|
Aug 15
00:24 UTC
|
DAN
Dana
|
◎ Target | Dan Levy ★★★☆☆ #1939 | Equal Weight | $33.00→ $35.00+6.1% |
|
Aug 15
00:24 UTC
|
CUZ
Cousins Properties
|
◎ Target | David Rodgers not yet tracked | Outperform | $33.00→ $35.00+6.1% |
|
Aug 15
00:24 UTC
|
CTC.A
Canadian Tire
|
◎ Target | firm only | C$179.00→ C$199.00+11.2% | |
|
Aug 15
00:24 UTC
|
CTC.A
Canadian Tire
|
◎ Target | firm only | Buy | C$115.00→ C$220.00+91.3% |
|
Aug 15
00:24 UTC
|
CTC.A
Canadian Tire
|
◎ Target | firm only | Sec→ r Perform | C$180.00→ C$200.00+11.1% |
|
Aug 15
00:24 UTC
|
CTC.A
Canadian Tire
|
◎ Target | firm only | Sec→ r Perform | C$210.00→ C$209.00-0.5% |
|
Aug 15
00:24 UTC
|
CRWV
CoreWeave
|
◎ Target | Tyler Radke ★★★★★ #114 | Buy | $142.00→ $159.00+12.0% |
|
Aug 15
00:24 UTC
|
CRMD
CorMedix
|
◎ Target | Leonid Timashev ★★★★☆ #500 | Outperform | $13.00→ $14.00+7.7% |
|
Aug 15
00:24 UTC
|
CREX
Creative Realities
|
◎ Target | Jon Hickman ★☆☆☆☆ #2971 | Buy | $7.50→ $8.00+6.7% |
|
Aug 15
00:24 UTC
|
CRBU
Caribou Biosciences
|
◎ Target | Alec Stranahan ★★★☆☆ #980 | Buy | $6.00→ $5.00-16.7% |
|
Aug 15
00:24 UTC
|
COST
Costain Group
|
◎ Target | firm only | Buy | GBX 240→ GBX 275+14.6% |
|
Aug 15
00:24 UTC
|
CLBT
Cellebrite DI
|
◎ Target | Eric Martinuzzi ★★★☆☆ #1963 | Buy | $21.00→ $15.00-28.6% |
|
Aug 15
00:24 UTC
|
CLBT
Cellebrite DI
|
◎ Target | Rudy Kessinger ★★★★★ #122 | Buy | $22.00→ $15.00-31.8% |
|
Aug 15
00:24 UTC
|
CLBT
Cellebrite DI
|
◎ Target | Mike Cikos ★★★★★ #15 | Buy | $15.00→ $12.50-16.7% |
|
Aug 15
00:24 UTC
|
CLBT
Cellebrite DI
|
◎ Target | Brian Essex ★★★☆☆ #1795 | Overweight | $20.00→ $16.00-20.0% |
|
Aug 15
00:24 UTC
|
CHE.UN
Chemtrade Logistics Income Fund
|
◎ Target | firm only | Buy | C$17.25→ C$18.50+7.2% |
|
Aug 15
00:24 UTC
|
CGY
Calian Group
|
◎ Target | firm only | Buy | C$104.00→ C$109.00+4.8% |
|
Aug 15
00:24 UTC
|
CGY
Calian Group
|
◎ Target | firm only | Buy | C$100.00→ C$106.00+6.0% |
|
Aug 15
00:24 UTC
|
CGY
Calian Group
|
◎ Target | firm only | Outperform | C$90.00→ C$105.00+16.7% |
|
Aug 15
00:24 UTC
|
CGY
Calian Group
|
◎ Target | firm only | C$93.00→ C$107.00+15.1% | |
|
Aug 15
00:24 UTC
|
CELC
Celcuity
|
◎ Target | Gil Blum ★★★★☆ #371 | Buy | $157.00→ $140.00-10.8% |
|
Aug 15
00:24 UTC
|
CELC
Celcuity
|
◎ Target | Stephen Willey ★★★☆☆ #1161 | Buy | $175.00→ $150.00-14.3% |
|
Aug 15
00:24 UTC
|
CCOI
Cogent Communications
|
◎ Target | Christopher Schoell not yet tracked | Neutral | $17.00→ $11.00-35.3% |
|
Aug 15
00:24 UTC
|
CCL.B
CCL Industries
|
◎ Target | firm only | Outperform | C$100.00→ C$105.00+5.0% |
|
Aug 15
00:24 UTC
|
CCL.B
CCL Industries
|
◎ Target | firm only | Outperform | C$100.00→ C$107.00+7.0% |
|
Aug 15
00:24 UTC
|
CCL.B
CCL Industries
|
◎ Target | firm only | Outperform | C$104.00→ C$106.00+1.9% |
|
Aug 15
00:24 UTC
|
CCL.B
CCL Industries
|
◎ Target | firm only | Outperform | C$102.00→ C$104.00+2.0% |
|
Aug 15
00:24 UTC
|
CCL.B
CCL Industries
|
◎ Target | firm only | Buy | C$110.00→ C$115.00+4.5% |
|
Aug 15
00:24 UTC
|
CCL.B
CCL Industries
|
◎ Target | firm only | C$104.00→ C$113.00+8.7% | |
|
Aug 15
00:24 UTC
|
CCL.B
CCL Industries
|
◎ Target | firm only | C$103.00→ C$110.00+6.8% | |
|
Aug 15
00:24 UTC
|
CATX
Perspective Therapeutics
|
◎ Target | Alec Stranahan ★★★☆☆ #980 | Neutral | $6.00→ $5.00-16.7% |
|
Aug 15
00:24 UTC
|
CAS
Cascades
|
◎ Target | firm only | Sec→ r Outperform | C$16.00→ C$20.50+28.1% |
|
Aug 15
00:24 UTC
|
CARG
CarGurus
|
◎ Target | Ronald Josey ★★☆☆☆ #2500 | Neutral | $32.00→ $39.00+21.9% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.